Literature DB >> 28624437

The plasma membrane: Penultimate regulator of ADAM sheddase function.

Karina Reiss1, Sucharit Bhakdi2.   

Abstract

BACKGROUND: ADAM10 and ADAM17 are the best characterized members of the ADAM (A Disintegrin and Metalloproteinase) - family of transmembrane proteases. Both are involved diverse physiological and pathophysiological processes. ADAMs are known to be regulated by posttranslational mechanisms. However, emerging evidence indicates that the plasma membrane with its unique dynamic properties may additionally play an important role in controlling sheddase function. SCOPE OF REVIEW: Membrane events that could contribute to regulation of ADAM-function are summarized. MAJOR
CONCLUSIONS: Surface expression of peptidolytic activity should be differentiated from ADAM-sheddase function since the latter additionally requires that the protease finds its substrate in the lipid bilayer. We propose that this is achieved through horizontal and vertical reorganization of membrane nanoarchitecture coordinately occurring at the sites of sheddase activation. Reshuffling of nanodomains thereby guides traffic of enzyme and substrate to each other. For ADAM17 phosphatidylserine exposure is required to then induce its shedding function. GENERAL SIGNIFICANCE: The novel concept that physicochemical properties of the lipid bilayer govern the action of ADAM-proteases may be extendable to other functional proteins that act at the cell surface. This article is part of a Special Issue entitled: Proteolysis as a Regulatory Event in Pathophysiology edited by Stefan Rose-John.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  ADAM10; ADAM17; Activation; Cell membrane asymmetry; Scramblases

Mesh:

Substances:

Year:  2017        PMID: 28624437     DOI: 10.1016/j.bbamcr.2017.06.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Res        ISSN: 0167-4889            Impact factor:   4.739


  20 in total

1.  Characterization of Cerebrospinal Fluid BACE1 Species.

Authors:  Inmaculada Lopez-Font; Claudia P Boix; Henrik Zetterberg; Kaj Blennow; Javier Sáez-Valero
Journal:  Mol Neurobiol       Date:  2019-07-09       Impact factor: 5.590

2.  Substrate-selective protein ectodomain shedding by ADAM17 and iRhom2 depends on their juxtamembrane and transmembrane domains.

Authors:  Beiyu Tang; Xue Li; Thorsten Maretzky; Jose Manuel Perez-Aguilar; David McIlwain; Yifang Xie; Yufang Zheng; Tak W Mak; Harel Weinstein; Carl P Blobel
Journal:  FASEB J       Date:  2020-02-26       Impact factor: 5.191

Review 3.  Membrane properties that shape the evolution of membrane enzymes.

Authors:  Charles R Sanders; James M Hutchison
Journal:  Curr Opin Struct Biol       Date:  2018-03-27       Impact factor: 6.809

4.  Ouabain Accelerates Collective Cell Migration Through a cSrc and ERK1/2 Sensitive Metalloproteinase Activity.

Authors:  O Verdejo-Torres; C Flores-Maldonado; T Padilla-Benavides; J P Campos-Blázquez; I Larré; R Lara-Lemus; E Perez Salazar; M Cereijido; R G Contreras
Journal:  J Membr Biol       Date:  2019-04-30       Impact factor: 1.843

5.  Role of ADAM10 and ADAM17 in the Regulation of Keratinocyte Adhesion in Pemphigus Vulgaris.

Authors:  Daniela Kugelmann; Maresa Anders; Anna M Sigmund; Desalegn T Egu; Ramona A Eichkorn; Amir S Yazdi; Miklós Sárdy; Michael Hertl; Dario Didona; Takashi Hashimoto; Jens Waschke
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

6.  ADAM17 Boosts Cholesterol Efflux and Downstream Effects of High-Density Lipoprotein on Inflammatory Pathways in Macrophages.

Authors:  Vishal Kothari; Jingjing Tang; Yi He; Farah Kramer; Jenny E Kanter; Karin E Bornfeldt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-04-22       Impact factor: 10.514

Review 7.  Novel Approaches and Challenges of Discovery of Exosite Modulators of a Disintegrin and Metalloprotease 10.

Authors:  Dmitriy Minond
Journal:  Front Mol Biosci       Date:  2020-05-06

8.  Novel role of APP cleavage by ADAM10 for breast cancer metastasis.

Authors:  Justyna Wozniak; Andreas Ludwig
Journal:  EBioMedicine       Date:  2018-11-29       Impact factor: 8.143

Review 9.  Natural Killer Cell Responses in Hepatocellular Carcinoma: Implications for Novel Immunotherapeutic Approaches.

Authors:  Stefania Mantovani; Barbara Oliviero; Stefania Varchetta; Dalila Mele; Mario U Mondelli
Journal:  Cancers (Basel)       Date:  2020-04-09       Impact factor: 6.639

10.  Levels of ADAM10 are reduced in Alzheimer's disease CSF.

Authors:  Aitana Sogorb-Esteve; María-Salud García-Ayllón; Johan Gobom; Jordi Alom; Henrik Zetterberg; Kaj Blennow; Javier Sáez-Valero
Journal:  J Neuroinflammation       Date:  2018-07-25       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.